Drug
Oc-459 clinical trials
Also written OC000459.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Other names
Studies by the year they started
10 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 1
Oxagen Ltd (6) · Atopix Therapeutics, Ltd. (2) · Imperial College London (1) · Chiesi Farmaceutici S.p.A. (1)
Studies
Open first, then newest update. How each study uses oc-459 is read from its arms, and is right about nine times in ten.
Testing it · 10
- Effect of OC459 on the Response to Rhinovirus Challenge in AsthmaCompletedPhase 2Imperial College LondonNCT02660489Written as OC459
- Effect of OC000459 on Eosinophilic Airway Inflammation in Severe AsthmaCompletedPhase 2Chiesi Farmaceutici S.p.A.NCT02560610Written as OC000459
- Effect of OC000459 on Moderate to Severe Atopic DermatitisCompletedPhase 2Atopix Therapeutics, Ltd.NCT02002208Written as OC000459
- Evaluation of Metabolic Profile of OC000459CompletedPhase 1Atopix Therapeutics, Ltd.NCT02341521Written as OC000459
- Proof of Concept Study of OC000459 in Eosinophilic EsophagitisCompletedPhase 2Oxagen LtdNCT01056783Written as OC000459
- A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic RhinitisCompletedPhase 2Oxagen LtdNCT01448902Written as OC000459
- Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4CompletedPhase 1Oxagen LtdNCT01056575Written as OC000459
- Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic SubjectsCompletedPhase 2Oxagen LtdNCT01057927Written as OC000459
- OC000459 Bronchial Allergen ChallengeCompletedPhase 2Oxagen LtdNCT01056692Written as OC000459
- OC000459 Dose Finding Study in Hay Fever Sufferers.CompletedPhase 2Oxagen LtdNCT00697281Written as OC000459
Codes
What other systems call oc-459 · ClinicalTrials.gg INT006020
- UNII (FDA) 04XB9TB8OLTIMAPIPRANTConfirmed FDA, Wikidata
- Wikidata Q27247701oc-459Confirmed FDA, Wikidata
- DrugBank DB11900One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 04XB9TB8OL | TIMAPIPRANT | Confirmed FDA, Wikidata |
| Wikidata | Q27247701 | oc-459 | Confirmed FDA, Wikidata |
| DrugBank | DB11900 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.